SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
LITS

Lite Strategy, Inc. (LITS)

NASDAQ: LITS · Real-Time Price · USD
Healthcare · Biotechnology
$0.81+$0.01 (+1.56%)
 
Market cap
$24.1M
Insider Score
Market Cap$24.12M-58.0%
Revenue (ttm)n/a
Net Income-$51.49M
EPS-$1.41
Shares Out29.88M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend DateNov 16, 2023
Volume148,448
Open$0.80
Previous Close$0.79
Day's Range$0.77 - $0.82
52-Week Range$0.69 - $1.99
Beta0.04
Analystsnone
Price Targetn/a
Earnings DateNov 13, 2026
+1.91% (1D)
No price history available.

About LITS

Lite Strategy, Inc. a clinical-stage pharmaceutical company, focuses on the development of novel and differentiated therapies for the treatment of cancer. It is also involved in holding Litecoin tokens as a primary reserve asset. The company was formerly known as MEI Pharma, Inc. and changed its name to Lite Strategy, Inc. in September 2025. Lite Strategy, Inc. was incorporated in 2000 and is based in San Diego, California.

Address
9920 Pacific Heights Blvd., San Diego, CA, 92121, United States
Market Cap
24 million
Employees
5
Industrial Classification
Biotechnology

Lite Strategy, Inc. Stock Analysis — InsiderScore

Insider Score
See top-rated InsiderScore stocks ›
62nd Percentile Overall Score
LITS InsiderScore:76 / 99

Lite Strategy, Inc. scored higher than 62% of companies evaluated by InsiderBuying, and ranked 76th out of 239 stocks in the financials sector.

Scores are percentile-ranked against every company we scored that day, with extra weight given to the size and conviction of each purchase and the seniority of the buyer.

Dollars Committed

Insiders at Lite Strategy, Inc. bought $21.5K of stock across 1 purchase in the last 90 days, the largest of them $21.5K.

Stake Increase

The average purchase added about 22% to the buyer's existing holding. Doubling a stake earns full marks here; topping up an already large position earns very little.

New Positions

Every buyer already held stock, so each purchase is an increase rather than a first position.

This category carries 35% of the Insider Score.

What Are Insiders Doing?

Open-market buy / sell balanceNet Buying
Sold
$0
Bought
$21.55K

View the trades behind this meter — each links to its SEC Form 4 →

Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.

1 Day
+2.53%
5 Days
-18.18%
1 Month
-31.93%
6 Months
-27.68%
1 Year
-58.03%

$LITS stock is featured in our Insider Score Rankings, and Insider Trades datasets.

→ All Stock Lists

Recently reported changes in LITS holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by LITS's directors and management

Net Shares Purchased by Insiders−30k−15k02025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

LITS Estimated quarterly lobbying spending

Source: U.S. Senate LDA

LITS Revenue by Segment

$7.96MTotal
Cash and cash equivalents$4.28M53.78%
Loss on derivative liabilities, net$1.17M14.72%
Investments in SAFE and Token Warrants, at fair value$1.04M13.12%
Professional fees$651.00K8.18%
Asset management fee and advisory fees$516.00K6.48%
Legal fees$296.00K3.72%

As of: Q3 2026 (Sep 30, 2026) · Source: SEC EDGAR (10-Q)

U.S. Patents

New LITS patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to LITS from public contracts

Source: USAspending.gov

Bull Case vs Bear Case

AI-generated from LITS’s recent data — informational, not investment advice

Generating analysis…

What’s Behind the Score

Insider Activity
100% of score
75.57
Analyst Ratings
No data yet
—
News & Sentiment
No data yet
—

Recent Insider Activity

Buys
1
Sells
0
Buy Value
$21.55K
Distinct Buyers
1

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.